Consolidated Statements of Operations and Comprehensive Earnings and Loss - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Operating revenues (net of contractual allowances)	$ 53,381	$ 53,766
Less provision for bad debts of Healthcare Services segment	509	478
Net Revenues	52,872	53,288
Costs and expenses:
Salaries, wages and benefits	23,551	23,378
Provision for bad debts of Pharmacy segment	703	438
Supplies	1,774	1,844
Other operating expenses	5,125	5,616
Rent and lease expense	626	561
Impairments	0	1,427
Depreciation and amortization	1,858	1,914
EHR incentive payments	(21)	(64)
Operating loss	(1,994)	(4,510)
Other income (expense):
Gain on economic damages claim, net	944	0
Interest expense	(359)	(635)
Loss on extinguishment of debt-net	(238)	(243)
Gain on sale of assets-net	169	2,917
Loss from continuing operations before income taxes	(1,478)	(2,471)
Income tax benefit	(345)	(512)
Loss from continuing operations	(1,133)	(1,959)
Earnings (loss) from discontinued operations, net of income taxes	(460)	4,647
Net earnings (loss)	(1,593)	2,688
Other comprehensive income	150	93
Comprehensive income (loss)	$ (1,443)	$ 2,781
Continuing operations:
Basic	$ (0.14)	$ (0.21)
Diluted	(0.14)	(0.21)
Discontinued operations:
Basic	(0.06)	0.50
Diluted	(0.06)	0.50
Net earnings (loss):
Basic	(0.19)	0.29
Diluted	$ (0.19)	$ 0.29
Weighted-average common shares outstanding:
Basic	8,283	9,346
Diluted	8,283	9,346
Product [Member]
Costs and expenses:
Cost of goods sold	$ 18,529	$ 19,917
Service [Member]
Costs and expenses:
Cost of goods sold	$ 2,721	$ 2,767